NewsBenzinga在诺和诺德资本市场日活动上,该公司美国负责人表示,自一月份以来,诺和诺德在肥胖领域已获得大约8个份额点;整个Wegovy特许经营的50%和Wegovy片剂在美国的销售的90%现在来自自付渠道。 在诺和诺德资本市场日活动上,该公司美国负责人表示,自一月份以来,诺和诺德在肥胖领域已获得大约8个份额点;整个Wegovy特许经营的50%和Wegovy片剂在美国的销售的90%现在来自自付渠道。 Benzinga 2026.09.21 12:28 (GMT+0) Open on Benzinga Other news StoneX Maintains Buy on Rivian Automotive, Lowers Price Target to $20 Amer Sports Unleashes $1 Billion Buyback, Raises 2026 Outlook EXCLUSIVE: Tesla Still Rules Leveraged ETFs, but Anthropic IPO and Micron’s Rise Signal What’s Next StoneX Reiterates Hold on iQIYIto Hold StoneX Maintains Buy on Baidu, Lowers Price Target to $125 Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide
Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide